Affinity Asset Advisors, LLC Innate Pharma Sa Transaction History

Affinity Asset Advisors, LLC

  • $579 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$4.34 - $6.06 $542,500 - $757,500
-125,000 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$3.04 - $8.1 $380,000 - $1.01 Million
125,000 New
125,000 $771,000

Others Institutions Holding IPHA

# of Institutions
9
Shares Held
238K
Call Options Held
0
Put Options Held
0
View Full List

About Innate Pharma SA

IPHA Quotes by TradingView
  • Ticker IPHA
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,893,000
  • Market Cap $115M
  • Description
  • Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...
More about IPHA
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email